Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2010
04/28/2010CN1595148B Process for determining paper inking property
04/28/2010CN1595147B Detection method for hydroxy asiaticoside and asiaticosede content for Sanjin preparation
04/28/2010CN1573314B Early determination of assay results
04/28/2010CN1496271B Method of treating diseases in association with decrease in expression of AOP-1 gene or AOP-1 and remedies for diseases
04/28/2010CN1489693B Method and devices for quantitation of glycated protein
04/28/2010CN1468307B Anti-dual integrin antibodies, compositions, methods and uses
04/28/2010CN1443085B Method for locating compounds which are suitable for treatment and/or prophylaxis of obesity
04/28/2010CN101699295A Integral cabinet type water quality automatic monitoring device
04/28/2010CN101699293A Time-resolved fluoroimmunoassay kit for detecting fumonisins B1 and detection method thereof
04/28/2010CN101699292A Rabbit monoclonal antibody based ciprofloxacin residue analysis enzyme-linked immune adsorption kit
04/28/2010CN101699291A Method for determining cross antigen region initiating human antigens in human enterovirus 71-type total protein
04/28/2010CN101699290A Method for testing mycoplasma pneumoniae antibody, gold-labeled quick test card and preparation method
04/28/2010CN101699289A Method for detecting toxoplasma antibody, gold-marked detection card and preparation method thereof
04/28/2010CN101699288A Method for detecting microcystin-LR by self-assembly based on end face of gold nano-rod
04/28/2010CN101699287A Homogeneous phase sol particle type cystatin C measuring kit and preparation method thereof
04/28/2010CN101699286A Method for quantitatively detecting ampicillin by marking antibody with laterally assembled gold nanorod
04/28/2010CN101699285A Friction reducing device
04/28/2010CN101699284A Frozen-soil experiment system capable of applying dynamic load
04/28/2010CN101699283A Intelligent food safety detection system and detection method
04/28/2010CN101699282A Device for measuring acid/rock reaction dynamics parameters of acid liquid systems with different viscosities
04/28/2010CN101699268A Rapid judgment for corrosion of sodium bicarbonate water type oil well and corrosion inhibitor
04/28/2010CN101698832A Production of gluten protein monoclonal antibody and application of cell strain thereof
04/27/2010USRE41277 protein D is an Ig receptor for human IgD and has an apparent molecular weight of 42,000; protein D can be detected in all of 116 encapsulated and non-encapsulated isolates of H. influenzae studied
04/27/2010US7706983 Method for anonymously registering, storing and using body material and/or information derived therefrom
04/27/2010US7706591 Neuronal profiling
04/27/2010US7705985 Method and apparatus for testing fibres
04/27/2010US7705199 Using modulators of toll-like receptor and/or uncooridinated protein activities as therapeutic agents in treatment of diabetes, multiple sclerosis, rheumatoid arthritis and addison's diseases
04/27/2010US7705197 Embryo development and survival
04/27/2010US7705196 sFRP expression enhancing agent
04/27/2010US7705195 Screening method
04/27/2010US7705150 Cyanine dyes
04/27/2010US7705131 Method for diagnosing selected adenocarcinomas
04/27/2010US7705129 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
04/27/2010US7705126 Compositions for controlling hair growth
04/27/2010US7705121 Chimeric human T1R3 taste receptor polypeptides and compositions containing same
04/27/2010US7704969 Transfection complexes
04/27/2010US7704964 Methods and compounds for the targeting of protein to exosomes
04/27/2010US7704952 treating diabetes or obesity using isolated polypeptide is covalently modified with a water-soluble polymer
04/27/2010US7704756 Such as acylated fluorescein dye for use as reporter molecules for detecting cell entry by molecules; detectable signal upon uptake by a cell; high throughput screening; solid phase synthesis
04/27/2010US7704755 Differential labelling method
04/27/2010US7704754 Using protein-nanoparticle fusions as diagnostic tools in detection of preferential particles on surfaces; nanotechnology and environmental cleanup, sanitization and quality of human health
04/27/2010US7704753 Devices and methods for analyte assays with built-in result reporting using recognizable symbols
04/27/2010US7704752 Reacting sample with boronate-coumarin derivatives and mesuring color, absorbance, fluorescence, chemiluminescence, and/or bioluminescence
04/27/2010US7704751 Polymeric fluorescent chemical sensor
04/27/2010US7704750 Visual spill indicator
04/27/2010US7704748 Gas analyzer for measuring the flammability of mixtures of combustible gases and oxygen
04/27/2010US7704747 comprises liquid crystal display and two holes for inserting measurement strips
04/27/2010US7704745 Apparatus and methods for monitoring the status of a metabolically active cell
04/27/2010US7704744 Methods for casein determination in milk
04/27/2010US7704736 Compositions for the derivation of germ cells from stem cells and methods of use thereof
04/27/2010US7704729 Using single test immunochromatographic strips to perform a fecal occult blood test; sample collection matrix being in communication with the sample and solvent application apertures of the front and rear panels; and an insertable test strip containing a reagent enabling detection of the analyte
04/27/2010US7704710 Expression vectors; transformed host cells; culturing the host cell to produce the encoded polypeptide; antiasthmatic agents
04/27/2010US7704703 Identifying modulators of tumor suppressor protein activity for use in treatment and prevention of infection and cell proliferative disorders
04/27/2010US7704702 hydrolysis of the chromogenic sialidase substrate 5-bromo-4-chloro-3-indolyl- alpha -D-N-acetylneuraminic acid (BCIN) in the presence of sialidase to yield indoxyl, reaction of produced indoxyl with nitro blue tetrazolium (NBT) to produce indigo and formazan which accumulate at the interface of matrices
04/27/2010US7704701 Diagnosis of prostate cancer with SPAS-1 cancer antigen
04/27/2010US7704700 Using concentration of inhibitors of apoptosis as biomarkers for prognosing successful survivability of patients undergoing cancer treatment
04/27/2010US7704699 mixing a crown ether, cryptand, or macrocyclic polyether with a large molecule such as peptide, protein, RNA, DNA, oligosacchride to form a non-covalent complex, performing electrospray ionization mass spectrometry to obtain spectral data of the large molecule-crown ether, cryptand, or polyether
04/27/2010US7704698 Human T2R51 taste receptor and related assays for identifying bitter taste modulators
04/27/2010US7704697 Nucleotide sequences coding protein 2A1of legionella for us as tool in diagnosis, prevention and treatment of legionnaires disease
04/27/2010US7704696 screening agents, conjugates or conjugate moieties for the ability to enter the CNS by crossing the blood brain barrier in order to treat or diagnose conditions within the CNS; organic cation transporter, a protein can transport carnitin; drug screening; treatment or diagnosis of neurological diseases
04/27/2010US7704695 screening agents, conjugates or conjugate moieties for the ability to enter the CNS by crossing the blood brain barrier in order to treat or diagnose conditions within the CNS; BGT1 transporter which is a protein can transport betaine; drug screening; treatment or diagnosis of neurological diseases
04/27/2010US7704687 Identifying chromosomal aberration associated with cell proliferative and hereditary disorders; cancer diagnosis
04/27/2010US7704686 Methods of identifying immunoregulatory agents, immunoregulatory agents, and uses thereof
04/27/2010US7704543 Obtaining a high density, reproducible and uniform coverage of a solid surface suitable for solid state synthesis and biosynthesis; aminosilanation of activated glass reacted with a diester of trimesic acid and N-hydroxysuccinimide followed by hydrolysis; attaching of DNA, proteins, biopolymers
04/27/2010US7704507 Anticancer vaccine and diagnostic methods and reagents
04/27/2010US7704503 methods for screening test compounds capable of inhibiting, i.e., decreasing, limiting, blocking, or otherwise reducing, IL-17F bioactivity, and methods for diagnosing, prognosing, and monitoring the progress of, disorders related to IL-17F bioactivity, e.g., in patients with cystic fibrosis
04/27/2010US7704498 Antiproliferative agents; anticancer agents; composition comprising antagonist of a human ErbB4 receptor, in admixture with a pharmaceutically acceptable carrier; antagonist selected from group consisting of an antibody produced by a hybridoma selected from the group containing HER4.10H1.1A1
04/27/2010US7704497 Molecules with extended half-lives, compositions and uses thereof
04/27/2010US7704496 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
04/27/2010US7704490 inducing in a patient, at least one activity of IL-2 selected from increasing humoral immune responses and increasing cellular immune responses, by administering to said patient a therapeutically effective amount of a peptide sufficient to induce the activity
04/27/2010US7704395 Multiple laminar flow-based rate zonal or isopycnic separation with holographic optical trapping of blood cells and other static components
04/27/2010US7704363 microfluidics; electrophoresis; microfluidics
04/27/2010US7704214 Device and method for the quantitative determination of nitrogen oxides in exhaled air and application thereof
04/27/2010CA2683295A1 Method of monitoring and optimizing denaturant concentration in fuel ethanol
04/27/2010CA2571927C Methods involving micromosal prostaglandin e2 synthase
04/27/2010CA2541075C Homogeneous time-resolved energy transfer assay
04/27/2010CA2428224C Method of measuring platelet activation
04/27/2010CA2428074C A method for the detection of viable microorganisms
04/27/2010CA2413857C Pd-l2 molecules: pd-1 ligands and uses therefor
04/27/2010CA2387306C Assays for short sequence variants
04/27/2010CA2375244C Method and apparatus for x-ray diffraction analyses
04/27/2010CA2374377C Potassium channel kcnq5
04/27/2010CA2372698C Microarray-based subtractive hybridization
04/27/2010CA2371816C Phthalamide-lanthanide complexes for use as luminescent markers
04/27/2010CA2360779C Assay with reduced background
04/27/2010CA2354015C Rapid colorimetric method for measuring polymers in aqueous systems
04/27/2010CA2284099C Detection of endometrial cancer
04/27/2010CA2278465C Diagnosis and treatment of myocardial failure
04/27/2010CA2203758C Compositions for the detection of proteases in biological samples and methods of use thereof
04/27/2010CA2162353C Interferon-.gamma. production inducing polypeptide, monoclonal antibody, and agent for interferon-.gamma. susceptive disease
04/22/2010WO2010045651A1 Methods for analyzing drug response
04/22/2010WO2010045633A2 Measurement and analysis of leukotrienes
04/22/2010WO2010045611A2 Method for diagnosis and monitoring of disease activity and response to treatment in systemic lupus erythematosus (sle) and other autoimmune diseases
04/22/2010WO2010045589A2 Optimizing erythropoietin therapy
04/22/2010WO2010045558A1 Method of determining a phosphorus binder dosage for a dialysis patient
04/22/2010WO2010045495A2 Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof
04/22/2010WO2010045490A2 Human biomarker hypermapping for depressive disorders
04/22/2010WO2010045475A1 Techniques for predicting hiv viral tropism and classifying amino acid sequences
04/22/2010WO2010045470A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of hepatic disorders
04/22/2010WO2010045467A1 Sensor system with close-loop-adsorption circulation